Interim analysis results are reviewed
The Data and Safety Monitoring Board (DSMB) reviews the results of the interim analysis. This is a critical point during the conduct of a clinical trial as the DSMB may recommend that the study be stopped the trial for futility in relation to the outcome. The DSMB recommends that the D2d study proceed to completion as planned. The D2d team is very pleased.